Marshall Wace, LLP DICERNA PHARMACE Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-80,116 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
80,116 New
80,116 $1.62 Million
Q1 2021

May 17, 2021
SELL
N/A
-31,591 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
N/A
-73,818 Reduced 70.03%
31,591 $696,000
Q3 2020

Nov 16, 2020
BUY
N/A
105,409 New
105,409 $1.9 Million
Q2 2020

Aug 13, 2020
SELL
N/A
-247,695 Closed
0 $0
Q1 2020

May 15, 2020
SELL
N/A
-732,175 Reduced 74.72%
247,695 $4.55 Million
Q4 2019

Feb 14, 2020
BUY
N/A
824,583 Added 531.01%
979,870 $21.6 Million
Q3 2019

Nov 14, 2019
BUY
N/A
155,287 New
155,287 $2.23 Million
Q2 2019

Aug 14, 2019
SELL
N/A
-202,213 Closed
0 $0
Q1 2019

May 14, 2019
BUY
N/A
202,213 New
202,213 $2.96 Million
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email